Recommended to use two new drugs to treat Covid-19 infections
According to the developing group guidelines in this regard at the UN Health Agency, this drug is strongly recommended for the treatment of critically ill infections and must be given in combination with corticosteroids.
A group of international experts said in its recommendation that there are some facts that could save patients’ lives and also reduce the need to use a ventilator.
Side effects of this medicine have not been observed.
Experts have advised against the use of two other drugs, ruxolitinib and tofacetinib in the treatment of critically ill patients.
They say that during the trial, these drugs did not show any benefit, while the use of tofacitinib showed serious side effects.
Less serious cases
In parallel, the UN Health Agency recommends the conditional use of a monoclonal antibody called ‘Sotrovimab’ in less severe infections.
Health experts say the drug should only be given to patients who are most at risk of hospitalization.
Patients who are not at high risk have seen only minor side effects from this drug.
These recommendations are based on facts obtained after examining more than four thousand patients in less severe, severe and very-severe transition cases.
The UN agency says this will help doctors in treating infections and that these guidelines are expected to be useful in a rapidly changing situation.